John Reynders
Moderna Therapeutics has appointed John Reynders as its first Chief Information Officer.
Reynder joins Moderna from AstraZeneca, where he served as Vice President of R&D Information, and has previously held senior leadership positions over the past decade at Johnson & Johnson, Lilly, and Celera Genomics.
Stephane Bancel , founding president and CEO of Moderna, said: “John has long been on the forefront of the information revolution that is reshaping drug development and healthcare, and he has a strong vision for how we can design an information resource capable of propelling Moderna – and the entire field of messenger RNA therapeutics – well into the future.”
And the news comes just weeks after Moderna appointed Henri Termeer, Genzyme's retired chairman, president, and CEO to its board.